Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Through System Optimization and Real-Time Blood Data Monitoring
Launched by CHUNG SHAN MEDICAL UNIVERSITY · Feb 13, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a new intelligent care system can improve the experience of patients undergoing radiation therapy, especially when combined with chemotherapy. The study focuses on using real-time blood monitoring to alert healthcare providers about any unusual test results, so they can act quickly if needed. It also aims to provide clearer educational materials to help patients better understand their treatment and communicate their health needs. By enhancing patient safety and reducing anxiety, the trial hopes to improve how well patients follow their treatment plans.
To be eligible for this study, participants must be at least 18 years old and currently receiving radiation therapy with chemotherapy. They should be able to understand and follow the study guidelines and be willing to provide consent. Those with severe cognitive issues or mental health conditions that may affect their participation will not be included. If you join the study, you'll receive additional support and reminders during your treatment, and your experiences will be compared to those of patients receiving standard care over a year.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing radiation therapy combined with chemotherapy.
- • Age ≥ 18 years.
- • Ability to understand and comply with the study protocol.
- • Willing to participate in the study and provide informed consent.
- Exclusion Criteria:
- • Patients with severe cognitive impairment or intellectual disability, affecting their ability to understand or follow study procedures.
- • Patients unwilling to complete study questionnaires.
- • Any mental health condition (e.g., major depressive disorder, severe anxiety disorder) that could interfere with participation.
- • Patients with conditions requiring immediate intervention that would make study participation impractical.
About Chung Shan Medical University
Chung Shan Medical University is a distinguished academic institution dedicated to advancing medical education, research, and healthcare services. As a clinical trial sponsor, the university leverages its expertise in medical sciences and innovative research methodologies to conduct rigorous and ethically sound clinical studies. With a commitment to enhancing patient care and contributing to the global body of medical knowledge, Chung Shan Medical University collaborates with healthcare professionals and research institutions to explore new therapeutic interventions and improve clinical outcomes. Through its comprehensive approach to research, the university plays a pivotal role in fostering advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung City, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported